The deal between Pfizer and AstraZeneca to acquire its London based business were halted with no plans to resume said sources who spoke in condition of anonymity as the matter was held private in nature.
Tags: Pfizer Inc
Pfizer increases its drugs prices including Lyrica and Viagra
Pfizer today confirmed that the company has increased the price of some of its drugs although it was not revealed how many drugs are involved with the price hike. According to a data by Wolters Kluwer which revealed that more than 100 types of drugs has been increased in its price starting on January 1st.
Pfizer's Arthritis Drug Patent Rejected in India
Pfizer Inc. has failed again in enforcing its intellectual property rights in India. The giant pharmaceutical's patent on its rheumatoid arthritis drug, Tofacitinib, was rejected in the country.
Investors seek protection against healthcare stock decline
Healthcare companies on a seven-year tear have been top performers so far in 2015, helping to push broad stock indexes to record levels, but traders are now looking to protect themselves from a selloff as they await major earnings reports in the sector.
Biogen shortens name, expands ambitions in Alzheimer's, ALS
Biogen Idec Inc has seen its market value quadruple in three years to more than $100 billion on the back of its successful multiple sclerosis drugs. Now it has new ambitions in its sights.
Latest News
Pharma giants Novartis International AG and Merck & Co. Inc. are reportedly negotiating an asset trade of about $5 billion each. Novartis wants to exchange its animal health and human vaccines businesses for Merck's over-the-counter health products unit.
Pfizer Ltd, the Indian unit of U.S. drug maker Pfizer Inc, is to take over local affiliate Wyeth Ltd. Shareholders of Wyeth will get seven Pfizer Ltd shares for every 10 shares held.
A Saturday announcement revealed that Pfizer Ltd, Pfizer Inc's Indian unit, would be merging with its local affiliate Wyeth Ltd after both pharmaceutical firms' boards approved the deal.
Pharmaceutical companies Novartis and Pfizer showing interest in Onyx (Photo : Reuters)Onyx Pharmaceuticals Inc Logo Pharmaceutical companies Novartis and Pfizer join the bandwagon as potential bidders for Onyx Pharmaceuticals Inc, sources close to the situation conferred on Monday.
U.S. Senator John Kerry and his wife intend to divest holdings in dozens of companies to avoid conflicts of interest if he is confirmed as U.S. secretary of state
Jeff Kindler, the former chief executive of Pfizer Inc, has joined venture capital firm Lux Capital as a partner.
1
